UTMD Financials: Utah Medical Products Inc AI Analysis



Financials

UTMD Financial

Utah Medical Products Inc

$64

-2.06%

$-1.34

At close: May 11, 16:00:00 GMT-4

$64

Post-market: May 11, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$65.35

Open

$64.62

Day's Range

$63.81 - $64.62

52 week range

$51.26 - $71.8

Volume

8.7K

Avg.Volume

14.7K

Dividend yield

1.87%

EPS (TTM)

3.48

Market Cap

$204.1M

What is UTMD?

Utah Medical Products, Inc. engages in the manufacturing, developing, and marketing of disposable and reusable medical devices. The company is headquartered in Midvale, Utah and currently employs 155 full-time employees. The firm markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit (NICU), the labor and delivery (L&D) department and the women's health center in hospitals, as well as medical devices sold to outpatient clinics and physician's offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device used immediately after birth to clear neonatal respiratory passages and reduce exposure to potential infections. AROM-CO is a finger cover with a prong designed to rupture maternal membranes with less patient pain and anxiety.

Features

Markets

News

Income

Balance sheet

Cash flow

Annual

Quarterly

UTMD Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024
Revenue	38	9	9	9	9	9
Revenue Growth (YoY)	-5%	0%	-10%	-10%	-18%	-25%
Cost of Revenue	16	3	4	4	4	3
Gross Profit	22	5	5	5	5	5
Selling, General & Admin	9	2	2	2	2	2
Research & Development	0	0	0	0	0	0
Operating Expenses	10	2	2	2	2	2
Other Non Operating Income (Expenses)	0	-2	0	0	0	-2
Pretax Income	14	3	3	3	3	3
Income Tax Expense	2	0	0	0	0	0
Net Income	11	2	2	3	3	2
Net Income Growth	-15%	0%	-33%	0%	0%	-50%
Shares Outstanding (Diluted)	3.19	3.19	3.2	3.24	3.31	3.38
Shares Change (YoY)	-6%	-6%	-8%	-8%	-9%	-7%
EPS (Diluted)	3.52	0.8	0.82	0.93	0.91	0.85
EPS Growth	-14%	-6%	-20%	-4%	-16%	-27%
Free Cash Flow	14	3	3	2	4	2
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	57.89%	55.55%	55.55%	55.55%	55.55%	55.55%
Operating Margin	28.94%	22.22%	22.22%	33.33%	33.33%	22.22%
Profit Margin	28.94%	22.22%	22.22%	33.33%	33.33%	22.22%
Free Cash Flow Margin	36.84%	33.33%	33.33%	22.22%	44.44%	22.22%
EBITDA	13	2	2	3	3	2
EBITDA Margin	34.21%	22.22%	22.22%	33.33%	33.33%	22.22%
D&A For EBITDA	2	0	0	0	0	0
EBIT	11	2	2	3	3	2
EBIT Margin	28.94%	22.22%	22.22%	33.33%	33.33%	22.22%
Effective Tax Rate	14.28%	0%	0%	0%	0%	0%

Follow-Up Questions

What are Utah Medical Products Inc's key financial statements?



According to the latest financial statement (Form-10K), Utah Medical Products Inc has a total asset of $0, Net loss of $0

What are the key financial ratios for UTMD?



Utah Medical Products Inc's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Utah Medical Products Inc's revenue broken down by segment or geography?



Utah Medical Products Inc largest revenue segment is Gynecology/Electrosurgery/Urology, at a revenue of 22,300,000 in the most earnings release.For geography, United States is the primary market for Utah Medical Products Inc, at a revenue of 30,413,000.

Is Utah Medical Products Inc profitable?



no, according to the latest financial statements, Utah Medical Products Inc has a net loss of $0

Does Utah Medical Products Inc have any liabilities?



no, Utah Medical Products Inc has liability of 0

How many outstanding shares for Utah Medical Products Inc?



Utah Medical Products Inc has a total outstanding shares of 0

Utah Medical Products Inc (UTMD) Financial

UTMD Stock Price Chart